Spire Wealth Management’s GoodRx Holdings GDRX Stock Holding History

Spire Wealth Management’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,000	Closed	-$11.3K	–	2400
2023 Q3	$11.3K	Hold	2,000	–	–	﹤0.01%	1696
2023 Q2	$11K	Hold	2,000	–	–	﹤0.01%	1779
2023 Q1	$12.5K	Hold	2,000	–	–	﹤0.01%	1769
2022 Q4	$9K	Hold	2,000	–	–	﹤0.01%	1652
2022 Q3	$9K	Buy	+2,000	New	+$12.6K	﹤0.01%	1592
2022 Q2	–	Sell	-1,000	Closed	-$19K	–	2732
2022 Q1	$19K	Sell	1,000 -500	-33%	-$11.5K	﹤0.01%	1832
2021 Q4	$49K	Buy	1,500 +500	+50%	+$20.1K	﹤0.01%	1745
2021 Q3	$41K	Hold	1,000	–	–	﹤0.01%	1561
2021 Q2	$36K	Sell	1,000 -8,800	-90%	-$325K	﹤0.01%	1627
2021 Q1	$369K	Buy	+9,800	New	+$441K	0.01%	775

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

LCM

Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return

PTC

Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Spire Wealth Management's GDRX Position: Q4 2023 in Review

Spire Wealth Management sold out of GoodRx Holdings (GDRX) in Q4 2023, closing a stake of 2,000 shares — an estimated $11.3K sold.

Spire Wealth Management first reported a position in GDRX in Q1 2021 and held it in 10 quarters. The position peaked at $369K in Q1 2021. 143 funds tracked by Wall St. Rank hold GDRX as of Q4 2023.

Spire Wealth Management reported no remaining GoodRx Holdings position as of Q4 2023 after selling out during the quarter.
Spire Wealth Management sold 2,000 GoodRx Holdings shares in Q4 2023, an estimated $11.3K.
Spire Wealth Management first reported a position in GoodRx Holdings in Q1 2021 and held it in 10 quarters.
Spire Wealth Management's GoodRx Holdings position peaked at $369K in Q1 2021.
143 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2023.

Based on Spire Wealth Management's 13F filing for Q4 2023, filed 6 Feb 2024.